LSV Asset Management Buys New Stake in PetIQ, Inc. (NASDAQ:PETQ)

LSV Asset Management bought a new stake in PetIQ, Inc. (NASDAQ:PETQ - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 43,005 shares of the company's stock, valued at approximately $849,000. LSV Asset Management owned about 0.15% of PetIQ at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Vanguard Group Inc. increased its stake in PetIQ by 13.4% in the third quarter. Vanguard Group Inc. now owns 1,918,500 shares of the company's stock valued at $37,794,000 after purchasing an additional 226,718 shares during the last quarter. Assenagon Asset Management S.A. grew its stake in shares of PetIQ by 13.8% during the 3rd quarter. Assenagon Asset Management S.A. now owns 416,878 shares of the company's stock valued at $8,212,000 after buying an additional 50,647 shares during the period. UBS Group AG increased its holdings in shares of PetIQ by 0.9% during the 3rd quarter. UBS Group AG now owns 400,488 shares of the company's stock worth $7,890,000 after buying an additional 3,382 shares during the last quarter. Charles Schwab Investment Management Inc. raised its position in shares of PetIQ by 3.7% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 203,914 shares of the company's stock worth $4,017,000 after buying an additional 7,309 shares during the period. Finally, EAM Investors LLC raised its position in shares of PetIQ by 70.7% in the 3rd quarter. EAM Investors LLC now owns 194,593 shares of the company's stock worth $3,833,000 after buying an additional 80,625 shares during the period. 94.99% of the stock is currently owned by hedge funds and other institutional investors.

PetIQ Stock Down 1.3 %

NASDAQ:PETQ traded down $0.25 during mid-day trading on Friday, hitting $18.44. The company had a trading volume of 331,678 shares, compared to its average volume of 282,658. The business has a fifty day simple moving average of $17.06 and a 200-day simple moving average of $17.99. The firm has a market capitalization of $542.71 million, a price-to-earnings ratio of 302.33 and a beta of 1.68. PetIQ, Inc. has a 1 year low of $12.19 and a 1 year high of $22.98. The company has a current ratio of 2.27, a quick ratio of 1.43 and a debt-to-equity ratio of 1.97.

PetIQ (NASDAQ:PETQ - Get Free Report) last announced its earnings results on Wednesday, February 28th. The company reported ($0.16) EPS for the quarter, beating the consensus estimate of ($0.38) by $0.22. The business had revenue of $219.93 million for the quarter, compared to the consensus estimate of $189.70 million. PetIQ had a return on equity of 11.72% and a net margin of 0.19%. Equities analysts forecast that PetIQ, Inc. will post 0.94 earnings per share for the current fiscal year.

Analysts Set New Price Targets

PETQ has been the subject of a number of research reports. Jefferies Financial Group boosted their price target on PetIQ from $24.00 to $28.00 and gave the company a "buy" rating in a research report on Tuesday, March 19th. Benchmark reiterated a "buy" rating and set a $30.00 target price on shares of PetIQ in a report on Friday. Four analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the stock has an average rating of "Buy" and an average price target of $29.00.

PetIQ Company Profile

PetIQ, Inc operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which sells flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and develops and manufactures its own proprietary value-branded products, as well as third-party branded products for dogs and cats.